Novartis signs up to $5.7 billion licensing deal with Monte Rosa Therapeutics - Yahoo Finance
Swiss drugmaker Novartis and drug developer Monte Rosa Therapeutics signed a licensing deal worth up to $5.7 billion on Monday to develop drugs for immune...
Comments